Evaluation Of Patient’S Visual Performance After Implantation Of Enhanced Monofocal Rayone Emv Intraocular Lens.

Published 2023 - 41st Congress of the ESCRS

Reference: PO0298 | DOI: 10.82333/hdk2-0j32

Authors: Wojciech Stanislaw Luboń* ¹ , Małgorzata Luboń ¹ , Mateusz Porwolik ¹ , Ewa Mrukwa-Kominek ¹

¹Department of Ophthalmology,University Clinical Center,Katowice,Poland;Department of Ophthalmology,Medical University of Silesia,Katowice,Poland

Aim of the work.
The aim of the study is to evaluate the patient’s performance and quality of life related to vision after implantation of enhanced monofocal non-diffractive RayOne EMV (Rayner, UK) intraocular lens.

Qualification of patients, surgery and all follow-ups were carried out in the Department of Ophthalmology of University Clinical Centre in Katowice.

20 patients (40 eyes) with cataract were qualified for implantation of

RayOne EMV intraocular lens.

The power of implanted lenses was calculated for emmetrophy using Barret TK Universal II formula (IOL Master 700, Zeiss). After surgery follow-up visits were planed 14 days, 1 and 3 months after surgery. Detailed ophthalmic evaluation was done including uncorrected visual acuity for far, intermediate and near distances, residual refraction using maximum plus technique, defocus curve, life quality related to vision using VF-14 questionnaire and assessment of halo and glare.

UCDVA was 0.01 logMAR (-0.10-0.20), mean UCIVA at 70 cm was 0.2 logMAR

(0.18-0.4), mean UCNVA for 40cm was 0.5 logMAR (0.4-0.6). Mean residual refractive error was less than -0,50D. Mean result of VF-14 questionnaire was 85/100 points. Occurrence of halo and glare was very low and none of the patient reported halos or glare disturbing driving at night.

Defocus curve showed visual acuity up to within 0.2 logMAR up to distance of 70 cm.

RayOne EMV intraocular lens provides good visual acuity for distant and intermediate distances. Rate of adverse visual effects is very low. This intraocular lens provide high patients satisfaction.